The immune response to SARS-CoV-2 in people with HIV
MA Höft, WA Burgers, C Riou - Cellular & Molecular Immunology, 2024 - nature.com
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
Analysis of postvaccination breakthrough COVID-19 infections among adults with HIV in the United States
Importance Recommendations for additional doses of COVID-19 vaccines for people with
HIV (PWH) are restricted to those with advanced disease or unsuppressed HIV viral load …
HIV (PWH) are restricted to those with advanced disease or unsuppressed HIV viral load …
The severity of COVID-19 across the spectrum of HIV
KW Miller, RT Gandhi - Current Opinion in HIV and AIDS, 2023 - journals.lww.com
People with HIV have faced increased challenges during the COVID-19 pandemic because
of high rates of comorbidities and social determinants of health as well as the impact of HIV …
of high rates of comorbidities and social determinants of health as well as the impact of HIV …
Common variable immunodeficiency disorders, T-cell responses to SARS-CoV-2 vaccines, and the risk of chronic COVID-19
R Ameratunga, H Longhurst, R Steele, K Lehnert… - The Journal of Allergy …, 2021 - Elsevier
COVID-19 has had a calamitous effect on the global community. Despite intense study, the
immunologic response to the infection is only partially understood. In addition to older age …
immunologic response to the infection is only partially understood. In addition to older age …
[HTML][HTML] Prolonged SARS-CoV-2 RNA shedding from therapy cat after cluster outbreak in retirement home
C Schulz, C Wylezich, K Wernike, M Gründl… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We report a therapy cat in a nursing home in Germany infected with severe acute respiratory
syndrome coronavirus 2 during a cluster outbreak in the home residents. Although we …
syndrome coronavirus 2 during a cluster outbreak in the home residents. Although we …
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for
coronavirus disease of 2019 (COVID-19), has caused havoc around the world. While …
coronavirus disease of 2019 (COVID-19), has caused havoc around the world. While …
[HTML][HTML] SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022
RA Teran, A Gagner, S Gretsch… - Emerging Infectious …, 2023 - ncbi.nlm.nih.gov
Understanding if persons with HIV (PWH) have a higher risk for SARS-CoV-2 reinfection
may help tailor future COVID-19 public health guidance. To determine whether HIV infection …
may help tailor future COVID-19 public health guidance. To determine whether HIV infection …
Prolonged severe acute respiratory syndrome coronavirus 2 delta variant shedding in a patient with AIDS: case report and review of the literature
We describe the case of a patient with AIDS who had persistent infection with a severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant for> 80 days. The variant …
respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant for> 80 days. The variant …
SARS-CoV-2 evolution and spike-specific CD4+ T-cell response in persistent COVID-19 with severe HIV immune suppression
H Álvarez, E Ruiz-Mateos, PM Juiz-González, J Vitallé… - Microorganisms, 2022 - mdpi.com
Intra-host evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
been reported in cases with persistent coronavirus disease 2019 (COVID-19). In this study …
been reported in cases with persistent coronavirus disease 2019 (COVID-19). In this study …
[PDF][PDF] COVID-19 in the immunocompromised host, including people with human immunodeficiency virus
N Jakharia, AK Subramanian, AE Shapiro - Infectious Disease Clinics of …, 2022 - Elsevier
This review describes the incidence, epidemiology, and risk factors for mortality of COVID-19
in immunocompromised patients, including persons with HIV. We describe various …
in immunocompromised patients, including persons with HIV. We describe various …